Type 2 diabetes Trials in Fortaleza, Brazil
Conditions / Type 2 diabetes / Fortaleza, Brazil
Type 2 diabetes is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01609582 | Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease | TERMINATED | PHASE3 |
| NCT03549754 | iCaReMe Global Registry | RECRUITING | — |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk | COMPLETED | — |
| NCT04657003 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight | COMPLETED | PHASE3 |
| NCT00255645 | G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study) | TERMINATED | — |
| NCT00658021 | Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00252876 | GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes | TERMINATED | PHASE3 |
| NCT04537923 | A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin | COMPLETED | PHASE3 |
| NCT00528879 | A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone | COMPLETED | PHASE3 |
| NCT00261352 | GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate | TERMINATED | PHASE3 |